Monday, June 6, 2022
- 7:00pm-8:00pm
-
Baseline Predictors of Antimicrobial Utilization in Solid Organ Transplant Recipients
All Infections (Excluding Kidney & Viral Hepatitis) III • Hynes Halls C & D
- 7:00pm-8:00pm
-
Batf3 and IRF4 in Control of iTreg Differentiation, Stability, and Survival
Treg/Other Regulatory Cell/Tolerance • Hynes Halls C & D
- 7:00pm-8:00pm
-
Belatacept Augments Mixed Chimerism in a Novel Nonhuman Primate Kidney Transplant Tolerance Induction Protocol
Immunosuppression & Tolerance: Preclinical & Translational Studies • Hynes Halls C & D
- 7:00pm-8:00pm
-
Benefits and Risks of Induction Immunosuppression Therapy in Pediatric Liver Transplantation
Liver: Pediatrics • Hynes Halls C & D
- 7:00pm-8:00pm
-
Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on Covid-19 Infection in Kidney Transplant Recipients
All Infections (Excluding Kidney & Viral Hepatitis) III • Hynes Halls C & D
- 7:00pm-8:00pm
-
Bilateral Renal Autotransplantation for Retroperitoneal Liposarcoma
Kidney Technical • Hynes Halls C & D
- 7:00pm-8:00pm
-
Biopsy and Blood Gene Expression Profiles Distinguish Injury, Subclinical and Clinical Rejection in Kidney Transplant Recipients
Biomarkers: -omics and Systems Biology • Hynes Halls C & D
- 7:00pm-8:00pm
-
BK Polyomavirus Infection is Not Associated with a Meaningful Increase in Donor-Derived Cell-Free DNA
Kidney: Polyoma • Hynes Halls C & D
- 7:00pm-8:00pm
-
BK Viremia in Living vs Deceased Donor Renal Transplant Recipients Receiving Alemtuzumab Induction
Kidney: Polyoma • Hynes Halls C & D
- 7:00pm-8:00pm
-
Blood Transcriptomes of Kidney Recipients with Covid-19 Demonstrate Deficient Adaptive Immune Activation
Biomarkers: -omics and Systems Biology • Hynes Halls C & D
- «Previous Page
- 1
- …
- 22
- 23
- 24
- 25
- 26
- …
- 52
- Next Page»